Thermo Fisher Scientific Inc. (LON:0R0H)

Market Cap	158.46B -8.1%
Revenue (ttm)	33.11B +3.9%
Net Income	4.98B +5.8%
EPS	13.18 +7.3%
Shares Out	n/a
PE Ratio	31.81
Forward PE	23.67
Dividend	1.29 (0.22%)
Ex-Dividend Date	Dec 15, 2025

Volume	1,202
Average Volume	1,339
Open	592.16
Previous Close	590.69
Day's Range	574.82 - 597.90
52-Week Range	385.88 - 643.49
Beta	0.91
RSI	38.52
Earnings Date	Jan 29, 2026

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company’s Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery and production of drugs and vaccines, as well as diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for phar...

• Industry: Medical - Pharmaceuticals
• Sector: Healthcare
• Founded: 1956
• Employees: 125,000
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0R0H

Financial Performance

In 2025, Thermo Fisher Scientific's revenue was $44.56 billion, an increase of 3.91% compared to the previous year's $42.88 billion. Earnings were $6.70 billion, an increase of 5.82%.

Financial numbers in USD